Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACS

NCT02048228 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

CLOPIDOGREL, POOR METABOLISM of (Disorder)

Interventions

DRUG: genotyping guided therapy Ticagrelor, Clopidogrel
DRUG: standard therapy clopidogrel

Sponsor

Chinese PLA General Hospital